RedBall Acquisition Corp. (RBAC) Prices $500M IPO
by Nicholas Alan Clayton on 2020-08-12 at 6:50pm

RedBall Acquisition Corp. announced the pricing of its $500 million IPO tonight and units are expected to begin trading under the ticker RBAC.U on the NYSE tomorrow, August 13th.

Sporting a deep roster of talented managers, RedBall aims to find a candidate to create the rare publicly-listed sports franchise in the next 24 months. The team is headlined by Billy Beane – the former Oakland A’s general manager and executive who pioneered “Moneyball” techniques of leveraging performance analytics to generate the best ROI on player acquisitions.

Co-chairing the Board with Beane is Gerald Cardinale, who leads RedBird Capital Partners, and has a long list of wins on his resume including helping to create the Yankees Entertainment & Sports (YES) Network. Alec Scheiner, a former Dallas Cowboys and Cleveland Browns executive, serves as Redball’s CEO.

Total SPAC deal count for 2020 year-to-date is now 67 with $26.56 billion in gross proceeds raised. The offering is anticipated to close on Monday, August 10, 2020.


Goldman Sachs & Co. LLC is acting as the sole book-running manager for the offering. Fried, Frank, Harris, Shriver & Jacobson LLP and White & Case LLP, were Issuer’s Counsel and Underwriter’s Counsel, respectively. WithumSmith+Brown, PC, acted as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

 

Recent Posts
by Nicholas Alan Clayton on 2024-03-01 at 1:28pm

News and Rumors Bloomberg: Digital World (NASDAQ:DWAC) and its target Trump Media and Technology Group (TMTG) were hit by a new wave of legal headaches this week as both the founders of its Truth Social platform and Digital World CEO Patrick Orlando filed lawsuits over the deal’s closing share allocations. One of the suits has...

by Nicholas Alan Clayton on 2024-03-01 at 10:52am

Altitude (NASDAQ:ALTU) has entered into a definitive agreement to combine with Vesicor Therapeutics for $70 million in equity consideration. San Gabriel, California-based Vesicor is developing treatments utilizing extracellular vesicles as both a therapy themselves and as a delivery system for other medicines. Transaction Overview Altitude has about $10.3 million in its current trust after seeing...

by Nicholas Alan Clayton on 2024-03-01 at 7:45am

At the SPAC of Dawn February finished as a productive month for SPACs with 11 closing combinations, up from just four in January. And, while regular way IPOs are taking back the driver’s seat in terms of new issuance in 2024, it isn’t by a wide margin. There were actually more SPAC closings than the...

by Nicholas Alan Clayton on 2024-02-29 at 3:26pm

Twelve companies and sponsors are set to be released to trade their shares in the final month of the quarter with both sides of the transaction being unlocked together in all but two cases. The first of those exceptions is the sponsor of Summit Healthcare who may begin trading shares on March 17 alongside insider...

by Nicholas Alan Clayton on 2024-02-29 at 1:44pm

News and Rumors Bloomberg: Online brokerage Webull made a point to divest its crypto business ahead of announcing its SPAC deal with SK Growth (NASDAQ:SKGR), its CEO Anthony Denier said, noting that previous attempts to list via a traditional IPO stalled. “The SEC has not been friendly [to crypto], which is widely known,” he added....

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved